Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital
Nolan S, Kelian S, Kerr T, Young S, Malmgren I, Ghafari C, Harrison S, Wood E, Lysyshyn M, Holliday E., Alcohol Depend. 2022
Challenges and opportunities for further research involving the cannabis-to-opioid use transition
Bahji A, Milloy MJ, Bach P, Sociás ME., Addiction. 2022
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial
Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Bruneau J, Fischer B, Rehm J, Wild TC, Wood E, Brissette S, Gagnon L, Fikowski J, Ledjiar O, Masse B, Socias ME; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse., Am J Psychiatry. 2022
Crack cocaine use frequency is associated with HIV disease severity independent of antiretroviral therapy exposure: a prospective cohort study
Macmadu A, Reddon H, Marshall BDL, Fairbairn N, Nolan S, Socías ME, Milloy MJ., AIDS Behav. 2022
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial
Socias ME, Wood E, Le Foll B, Lim R, Choi JC, Mok WY, Bruneau J, Rehm J, Wild TC, Bozinoff N, Hassan A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse.,
Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada
Ivsins A, MacKinnon L, Bowles JM, Slaunwhite A, Bardwell G., J Urban Health. 2022
Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions
Garel N, McAnulty C, Greenway KT, Lesperance P, Miron JP, Rej S, Richard-Devantoy S, Jutras-Aswad D., Drug and Alcohol Dependence, 2022
Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial
McAnulty C, Bastien G, Eugenia Socias M, Bruneau J, Le Foll B, Lim R, Brissette S, Ledjiar O, Marsan S, Talbot A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse., Drug Alcohol Depend. 2022
The tobacco-free fallacy: What paediatricians should know about herbal smoking products
Khorasani A., Chadi N., Paediatrics & Child Health, 2022
Social service providers’ perspectives on caring for structurally vulnerable hospital patients who use drugs: a qualitative study
Gehring ND, Speed KA, Dong K, Pauly B, Salvalaggio G, Hyshka E. , BMC Health Serv Res. 2022
